Nasdaq

Medtronic Receives CE Mark for InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence InterStim Micro is a ...
Nasdaq

Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Becker's ASC

InterStim in the ASC Setting: 2 Surgeons Weigh In

InterStim Therapy is a sacral neuromodulation therapy from Medtronic. InterStim has been regularly used for urinary incontinence for more than a decade, but recently received additional approval as ...
Yahoo Finance

Medtronic Submits Two Pelvic Health Devices for FDA's PMA

Medtronic plc. MDT has submitted its rechargeable, implantable sacral neuromodulation (SNM) device known as InterStim Micro neurostimulator for the FDA’s pre-market approval (PMA). This PMA supplement ...
Yahoo Finance

Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Stockhouse

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads

DUBLIN , Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
FierceBiotech

Medtronic's rechargeable neurostimulator implant nets FDA approval for bladder and bowel control

The InterStim Micro's rechargeable battery gives it an implant life of 15 years, and is 83% smaller than Medtronic's previous InterStim II, which needed to be surgically swapped out every three to ...
Healio

FDA approves expanded labeling for sacral neuromodulation systems with SureScan MRI leads

Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation ...
Pharmabiz

US FDA grants expanded MRI labeling for Medtronic’s InterStim SureScan MRI leads

Medtronic announced it has received approval from the United States Food and Drug Administration (FDA) for expanded MRI labeling of its InterStim II and InterStim Micro sacral neuromodulation (SNM) ...
Finanznachrichten

Medtronic plc: Medtronic Receives CE Mark for InterStim Micro Neurostimulator and InterStim SureScan MRI Leads

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence DUBLIN, Jan. 13, 2020 ...
Yahoo Finance

Medtronic Submits Two Pelvic Health Devices for FDA's PMA

Medtronic plc. MDT has submitted its rechargeable, implantable sacral neuromodulation (SNM) device known as InterStim Micro neurostimulator for the FDA’s pre-market approval (PMA). This PMA supplement ...